Company / Net Income
TEVA PHARMACEUTICAL INDUSTRIES LTD Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$1.4B
FY2025
5-year range
-$2.4B / $1.4B
FY2021-FY2025
Trend
+186.0%
vs FY2024
Sector context
#14 of 216
Health Care
What the data says
Among 216 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 6% for net income. Net Income has fluctuated over the past 10 years, ranging from -$16.3B in FY2017 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025. Top quartile in the Health Care sector.
Improved from -$559M to $1.4B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 216This company $1.4B Sector average $454.1M
▼
+210.5% above sector average
Key checks
Key Insights
- In FY2025, net income increased 186.0% year-over-year.
- Ranks #14 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +186.0% |
| FY2024 | -$1.6B | -193.2% |
| FY2023 | -$559.0M | +77.1% |
| FY2022 | -$2.4B | -686.6% |
| FY2021 | $417.0M | +110.5% |
| FY2020 | -$4.0B | -299.4% |
| FY2019 | -$999.0M | +53.5% |
| FY2018 | -$2.1B | +86.8% |
| FY2017 | -$16.3B | -5043.8% |
| FY2016 | $329.0M | -79.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026